Tikcro Technologies Ltd. focuses on an early stage biotechnology project in Israel.
Adequate balance sheet and overvalued.
Share Price & News
How has Tikcro Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TIKR.F has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: TIKR.F exceeded the US Biotechs industry which returned 14% over the past year.
Return vs Market: TIKR.F exceeded the US Market which returned 17.9% over the past year.
Price Volatility Vs. Market
How volatile is Tikcro Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Tikcro Technologies undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate TIKR.F's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate TIKR.F's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: TIKR.F is unprofitable, so we can't compare its PE Ratio to the Biotechs industry average.
PE vs Market: TIKR.F is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TIKR.F's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TIKR.F is good value based on its PB Ratio (0.7x) compared to the US Biotechs industry average (3.3x).
How is Tikcro Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tikcro Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Tikcro Technologies's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Tikcro Technologies's filings and announcements here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has Tikcro Technologies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TIKR.F is currently unprofitable.
Growing Profit Margin: TIKR.F is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TIKR.F is unprofitable, and losses have increased over the past 5 years at a rate of -9.7% per year.
Accelerating Growth: Unable to compare TIKR.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TIKR.F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (66.2%).
Return on Equity
High ROE: TIKR.F has a negative Return on Equity (-26.78%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is Tikcro Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: TIKR.F's short term assets ($4.6M) exceed its short term liabilities ($264.0K).
Long Term Liabilities: TIKR.F has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: TIKR.F is debt free.
Reducing Debt: TIKR.F has not had any debt for past 5 years.
Inventory Level: TIKR.F has a low level of unsold assets or inventory.
Debt Coverage by Assets: TIKR.F's debt is not covered by short term assets (assets are -68x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if TIKR.F has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if TIKR.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Tikcro Technologies's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate TIKR.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate TIKR.F's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TIKR.F's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TIKR.F's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TIKR.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Aviv Boim (51yo)
Mr. Aviv Boim has been the Chief Executive Officer of Tikcro Technologies Ltd. since November 2010. Mr. Boim served as the Chief Financial Officer and General Manager of Israel of Imperva Inc. since Septem ...
CEO Compensation Analysis
Compensation vs Market: Aviv's total compensation ($USD339.00K) is below average for companies of similar size in the US market ($USD522.48K).
Compensation vs Earnings: Aviv's compensation has increased whilst the company is unprofitable.
|External Director||4.1yrs||US$21.00k||no data|
|Chairman of the Board||20.1yrs||US$15.00k||10.75% $307.8k|
|External Director||1.1yrs||no data||no data|
|Independent Director||1.1yrs||no data||no data|
Experienced Board: TIKR.F's board of directors are considered experienced (4.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Tikcro Technologies Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Tikcro Technologies Ltd.
- Ticker: TIKR.F
- Exchange: OTCPK
- Founded: 1999
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$2.864m
- Shares outstanding: 9.88m
- Website: https://www.tikcro.com
Number of Employees
- Tikcro Technologies Ltd.
- 7 Sapir Street
- 5th Floor
- Ness Ziona
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|TIKR.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Jun 2000|
Tikcro Technologies Ltd. focuses on an early stage biotechnology project in Israel. The company engages in the development of anti-cytotoxic T-lymphocyte-associated protein 4 and antibodies selected and verified in pre-clinical trials with a focus on antibodies targeting immune modulator pathways for cancer treatment. The company was formerly known as Tioga Technologies Ltd. and changed its name to Tikcro Technologies Ltd. in September 2003. Tikcro Technologies Ltd. was founded in 1999 and is headquartered in Ness Ziona, Israel.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/23 00:15|
|End of Day Share Price||2020/02/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.